<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02759497</url>
  </required_header>
  <id_info>
    <org_study_id>sbp diagnosis</org_study_id>
    <nct_id>NCT02759497</nct_id>
  </id_info>
  <brief_title>Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis</brief_title>
  <official_title>Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the most common and serious complications in decompensated cirrhotic patients (DCPs)
      is bacterial infection.The most common infections in DCPs are cases of spontaneous bacterial
      peritonitis (SBP), which account for 40% 70% of cases, followed by urinary tract infections,
      pneumonia and cellulitis.

      Serum amyloid A (SAA) and C-reactive protein (CRP) are acute-phase proteins predominantly
      produced and secreted by hepatocytes. Other cells including lymphocytes, monocytes, and
      macrophages can also produce these proteins. The induction of SAA and CRP synthesis is
      triggered by a number of cytokines, chiefly IL-6, which is released from a variety of cell
      types, but mainly from macrophages and monocytes at inflammatory sites
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Increased serum CRP and SAA levels have been found in a number of disorders, including
      bacterial infections, malignancies tissue injuries and tissue rejection. Therefore, new
      studies of early diagnosis, prevention and treatment are needed to improve clinical outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with elevated serum amyloid A</measure>
    <time_frame>6months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Spontaneous Bacterial Peritonitis</condition>
  <arm_group>
    <arm_group_label>Serum amyloid A level in SBP</arm_group_label>
    <description>serum amyloid A level</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Serum amyloid A level in cirrhosis</arm_group_label>
    <description>Serum amyloid A level</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>serum amyloid A level</intervention_name>
    <description>serum amyloid A level (SAA)</description>
    <arm_group_label>Serum amyloid A level in SBP</arm_group_label>
    <arm_group_label>Serum amyloid A level in cirrhosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Decompensated cirrhosis with SBP Decompensated cirrhosis without SBP
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  â€¢ Decompansated cirrhosis with ascites, defined by a combination of any of the
             following:

               -  Laboratory findings

               -  Endoscopic results

               -  Ultrasound

               -  Histology

        Exclusion Criteria:

          -  Creatinine&gt;1.5 mg/dl

          -  Other infection e.grespiratory,UTI ,gastrointestinal and skin infection.

          -  Hepatocellular carcinoma

          -  Other extrahepatic malignancy e.g ; chest

          -  Any significant psychiatric illness or other medical comorbidity.

          -  Any degenerative diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rehab Badawi, Consultant</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hepatology and gastroenterology dept.-Tanta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sherief Abd-Elsalam, Consultant</last_name>
    <role>Study Chair</role>
    <affiliation>Division of Gastroenterology and Hepatology- Tanta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Walaa Elkhalawany, Consultant</last_name>
    <role>Study Chair</role>
    <affiliation>Hepatology and gastroenterology dept.-Tanta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Reham Elkhouly, Consultant</last_name>
    <role>Study Chair</role>
    <affiliation>Hepatology and gastroenterology dept.-Tanta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mona Watany, Consultant</last_name>
    <role>Study Chair</role>
    <affiliation>clinical pathology dept.-Tanta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samah Soliman, Consultant</last_name>
    <role>Study Chair</role>
    <affiliation>Hepatology and gastroenterology dept.-Tanta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mai Khalaf, resident</last_name>
    <role>Study Chair</role>
    <affiliation>hepatology dept.-Tanta</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sherief Abd-Elsalam, Consultant</last_name>
    <phone>00201095159522</phone>
    <email>sheriefabdelsalam@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sherief Abd-Elsalam</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherief Abd-elsalam, lecturer</last_name>
      <phone>00201000040794</phone>
      <email>Sherif_tropical@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2016</study_first_submitted>
  <study_first_submitted_qc>May 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 3, 2016</study_first_posted>
  <last_update_submitted>June 17, 2017</last_update_submitted>
  <last_update_submitted_qc>June 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Sherief Abd-Elsalam</investigator_full_name>
    <investigator_title>Consultant liver and GIT diseases- Tanta university hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peritonitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

